Profil
Richard Jon Davis is currently an Independent Director at Nanexa AB since 2022 and the Chief Operating & Business Officer at Nouscom AG since 2020.
Previously, he served as the Chief Executive Officer at Trino Therapeutics Ltd. from 2014 to 2015.
He also held a position as a Non-Executive Director at Kymab Ltd. and worked as a Manager-Healthcare Investment at The Wellcome Trust Ltd. Dr. Davis obtained his undergraduate and doctorate degrees from the University of Leicester.
Aktive Positionen von Richard Davis
| Unternehmen | Position | Beginn |
|---|---|---|
| NANEXA AB | Direktor/Vorstandsmitglied | 01.07.2022 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Geschäftsführer | 23.05.2022 |
Ehemalige bekannte Positionen von Richard Davis
| Unternehmen | Position | Ende |
|---|---|---|
Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug discovery and development company | Vorstandsvorsitzender | - |
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides welfare and charitable services | Corporate Officer/Principal | - |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Direktor/Vorstandsmitglied | - |
Ausbildung von Richard Davis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous Provides welfare and charitable services | Miscellaneous |
University of Leicester
University of Leicester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Trino Therapeutics Ltd.
Trino Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug discovery and development company | Health Technology |
Nanexa AB
Nanexa AB Medical SpecialtiesHealth Technology Operates as a research intensive technology company | Health Technology |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Health Technology |
















